← Leaderboards
Donald Miguel Rodriguez
University Of Chicago
$152,792
Attributed
$152,792
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.2K · FY2020–22$100K$75K$50K$25K$0
'20
'21
'22
Funding mix
By agency
NIH$152,792 · 1
By mechanism
F30$152,792 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Michelle M Le Beau$39,023,275
- Peter Aidan Savage$14,017,592
- Yang-Xin Fu$17,180,976
- Jeffrey A Bluestone$76,504,040
- Albert S. Bendelac$31,264,054
Others in their field
Other Emerging Leaders on “Agonist”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Aaron Esser-Kahn · University Of Chicago$13,378,548
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Xinhua Li · Nano Terra, Inc.$11,941,250
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
Research focus
AgonistAffinityAutoantigensAutoimmunityAutomobile DrivingAntigensBiologyBone MarrowCd4 Positive T LymphocytesCell Differentiation ProcessCell LineageCellsChimera OrganismClonal DeletionClone CellsCollaborationsComplexDensityDraining Lymph NodeEngineeringEpitopesExclusionExhibitsFoxp3 Gene
Grant awards (3)
Impact of TCR-pMHC affinity on prostate-specific CD4+ T cell development and function$51,236
F30 · FY2022 · CA · contact PI
Impact of TCR-pMHC affinity on prostate-specific CD4+ T cell development and function$51,036
F30 · FY2021 · CA · contact PI
Impact of TCR-pMHC affinity on prostate-specific CD4+ T cell development and function$50,520
F30 · FY2020 · CA · contact PI